1. From the Department of Urology, University of California San Francisco Urology Outcomes Research Group and University of California San Francisco-Mount Zion Cancer Center, University of California San Francisco and Lewin-TAG, Inc., San Francisco, California, and TAP Holdings, Inc., Deerfield, Illinois